219 related articles for article (PubMed ID: 29797068)
1. Minimal Risk of Biliary Tract Complications, Including Hepatic Abscess, After Transarterial Embolization for Hepatocellular Carcinoma Using Concentrated Antibiotics Mixed with Particles.
Wang Q; Hodavance M; Ronald J; Suhocki PV; Kim CY
Cardiovasc Intervent Radiol; 2018 Sep; 41(9):1391-1398. PubMed ID: 29797068
[TBL] [Abstract][Full Text] [Related]
2. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma.
Chen C; Chen PJ; Yang PM; Huang GT; Lai MY; Tsang YM; Chen DS
Am J Gastroenterol; 1997 Dec; 92(12):2257-9. PubMed ID: 9399765
[TBL] [Abstract][Full Text] [Related]
3. The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma.
Tu J; Jia Z; Ying X; Zhang D; Li S; Tian F; Jiang G
Medicine (Baltimore); 2016 Dec; 95(49):e5606. PubMed ID: 27930585
[TBL] [Abstract][Full Text] [Related]
4. Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors.
Woo S; Chung JW; Hur S; Joo SM; Kim HC; Jae HJ; Park JH
AJR Am J Roentgenol; 2013 Jun; 200(6):1370-7. PubMed ID: 23701078
[TBL] [Abstract][Full Text] [Related]
5. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma.
Shin JU; Kim KM; Shin SW; Min SY; Park SU; Sinn DH; Gwak GY; Choi MS; Lee JH; Paik SW; Yoo BC; Koh KC
Dig Liver Dis; 2014 Sep; 46(9):813-7. PubMed ID: 24881853
[TBL] [Abstract][Full Text] [Related]
6. Liver abscess following transarterial chemoembolization for the treatment of hepatocellular carcinoma: A retrospective analysis of 23 cases.
Jia Z; Tu J; Cao C; Wang W; Zhou W; Ji J; Li M
J Cancer Res Ther; 2018 Sep; 14(Supplement):S628-S633. PubMed ID: 30249879
[TBL] [Abstract][Full Text] [Related]
7. Biliary complications of arterial chemoembolization of hepatocellular carcinoma.
Dhamija E; Paul SB; Gamanagatti SR; Acharya SK
Diagn Interv Imaging; 2015 Nov; 96(11):1169-75. PubMed ID: 26292615
[TBL] [Abstract][Full Text] [Related]
8. Liver abscess formation after transarterial chemoembolization for malignant hepatic tumor.
Huang SF; Ko CW; Chang CS; Chen GH
Hepatogastroenterology; 2003; 50(52):1115-8. PubMed ID: 12845993
[TBL] [Abstract][Full Text] [Related]
9. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma.
Kim HK; Chung YH; Song BC; Yang SH; Yoon HK; Yu E; Sung KB; Lee YS; Lee SG; Suh DJ
J Clin Gastroenterol; 2001; 32(5):423-7. PubMed ID: 11319315
[TBL] [Abstract][Full Text] [Related]
10. Are prophylactic antibiotics necessary prior to transarterial chemoembolization for hepatocellular carcinoma in patients with native biliary anatomy?
Watchmaker JM; Lipnik AJ; Fritsche MR; Baker JC; Mouli SK; Geevarghese S; Banovac F; Omary RA; Brown DB
J Surg Oncol; 2018 May; 117(6):1312-1317. PubMed ID: 29513895
[TBL] [Abstract][Full Text] [Related]
11. Liver Abscess Formation Following Transarterial Chemoembolization: Clinical Features, Risk Factors, Bacteria Spectrum, and Percutaneous Catheter Drainage.
Lv WF; Lu D; He YS; Xiao JK; Zhou CZ; Cheng DL
Medicine (Baltimore); 2016 Apr; 95(17):e3503. PubMed ID: 27124055
[TBL] [Abstract][Full Text] [Related]
12. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
Shin BS; Park MH; Jeon GS
Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
[TBL] [Abstract][Full Text] [Related]
13. Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism.
Sun Z; Li G; Ai X; Luo B; Wen Y; Zhao Z; Dong S; Guan J
Crit Rev Oncol Hematol; 2011 Aug; 79(2):164-74. PubMed ID: 20719529
[TBL] [Abstract][Full Text] [Related]
14. Acute ischemic cholecystitis after transarterial chemoembolization of hepatocellular carcinoma: incidence and clinical outcome.
Wagnetz U; Jaskolka J; Yang P; Jhaveri KS
J Comput Assist Tomogr; 2010; 34(3):348-53. PubMed ID: 20498534
[TBL] [Abstract][Full Text] [Related]
15. Empiric antibiotics for transarterial embolization in hepatocellular carcinoma: indicated?
Shelgikar CS; Loehle J; Scoggins CR; McMasters KM; Martin RC
J Surg Res; 2009 Jan; 151(1):121-4. PubMed ID: 18657833
[TBL] [Abstract][Full Text] [Related]
16. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
Kim MH; Choi MS; Choi YS; Kim DY; Lee JM; Paik SW; Lee JH; Koh KC; Yoo BC; Choi D; Rhee JC
Korean J Hepatol; 2006 Mar; 12(1):55-64. PubMed ID: 16565606
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of clinical prognosis and the correlation between bile duct injury after transcatheter arterial chemoembolization and the level of hepatic arterial embolization in patients with hepatocellular carcinoma].
Xu HY; Yu XP; Feng R; Hu HJ; Xiao WW
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):355-360. PubMed ID: 28535652
[No Abstract] [Full Text] [Related]
19. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome.
Song SY; Chung JW; Han JK; Lim HG; Koh YH; Park JH; Lee HS; Kim CY
J Vasc Interv Radiol; 2001 Mar; 12(3):313-20. PubMed ID: 11287508
[TBL] [Abstract][Full Text] [Related]
20. Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization.
Chu HJ; Lee CW; Yeh SJ; Tsai LK; Tang SC; Jeng JS
PLoS One; 2015; 10(6):e0129367. PubMed ID: 26107693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
